Physician

Ali Soueidan, M.D

According to 2025 Medicare claims, Ali Soueidan, M.D (NPI: 1053517540) practices pulmonary disease in the Warren-Troy-Farmington Hills, MI market, with the plurality of this provider's patient population coming from Oakland, MI. This provider's primary affiliated billing organization is CONSULTANTS IN SLEEP & PULMONARY MEDICINE PLLC (NPI: 1740353069; TIN: 38-3433632) and primary practice location at 48075-4803.

Soueidan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 505 traditional Medicare patients, billed 1,527 HCPCS/CPT codes, and received $194,062 in Medicare payments. The top billing code was 99291 (Critical care, first 30-74 minutes). Part D data shows 708 prescription claims across 155 beneficiaries totaling $360,235 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 375 claims. Open Payments data shows 36 records totaling $811. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $258,116 to $194,062. Similarly, Part D prescription costs have fallen sharply in recent years, from $453,751 to $360,235. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $103,121 and ending at $40,314.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	888	2,809	$258,116
2016	809	2,573	$242,975
2017	806	2,687	$248,542
2018	815	2,787	$248,256
2019	942	3,812	$299,481
2020	722	2,538	$230,076
2021	676	2,564	$215,171
2022	580	1,948	$178,232
2023	458	1,425	$170,918
2024	505	1,527	$194,062

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	321	1,346	$453,751
2016	312	1,590	$540,779
2017	308	1,694	$677,363
2018	317	1,681	$726,373
2019	340	1,634	$648,921
2020	351	1,913	$851,491
2021	367	2,018	$948,231
2022	305	1,375	$910,024
2023	135	398	$233,954
2024	155	708	$360,235

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	263	1,651	$121,380
2016	293	1,769	$93,291
2017	342	1,626	$82,090
2018	432	1,863	$87,729
2019	445	1,914	$118,991
2020	357	1,836	$150,478
2021	361	1,866	$180,494
2022	255	1,377	$105,363
2023	91	525	$25,080
2024	70	375	$28,031

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99291	Critical care, first 30-74 minutes	217	604	$170
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	40	40	$157
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	98	109	$136
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	75	104	$100
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	184	375	$94

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	263	10,320	$212,271
Breo Ellipta	Fluticasone/Vilanterol	90	3,780	$48,948
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	23	870	$18,040
Spiriva Respimat	Tiotropium Bromide	18	840	$13,791
Albuterol Sulfate Hfa	Albuterol Sulfate	97	3,553	$3,914

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0483	High frequency chest wall oscillation system, with full anterior and/or posterior thoracic region receiving simultaneous external oscillation, includes all accessories and supplies, each	Y	N/R	15	$12,544
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	11	80	$7,505
E0601	Continuous positive airway pressure (cpap) device	Y	14	58	$1,544
A7030	Full face mask used with positive airway pressure device, each	N	N/R	15	$1,305
E1392	Portable oxygen concentrator, rental	Y	N/R	33	$1,212

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	36	$811	Regeneron Healthcare Solutions, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ali Soueidan, M.D?

Tedicare shows public-source Medicare data for Ali Soueidan, M.D (NPI 1053517540), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ali Soueidan, M.D have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ali Soueidan, M.D?

Ali Soueidan, M.D is linked to CONSULTANTS IN SLEEP & PULMONARY MEDICINE PLLC (billing NPI 1740353069) in the available physician profile data.

Does Ali Soueidan, M.D have Open Payments data?

Ali Soueidan, M.D has 36 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.